Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

Clinical trial NCT05883306 · COMPLETED

Trial details

NCT number: NCT05883306
Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of 14C-labeled of LXI-15028

Start date: 2022-06-30
Primary completion: 2022-07-21
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.